<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="jia225048-tbl-0003" xml:lang="en" orientation="portrait" position="float">
 <label>Table 3</label>
 <caption>
  <p>Trial population characteristics at baseline</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1"> </th>
    <th align="left" valign="top" rowspan="1" colspan="1">BCPP</th>
    <th align="left" valign="top" rowspan="1" colspan="1">
     <italic>Max</italic>ART
    </th>
    <th align="left" valign="top" rowspan="1" colspan="1">PopART</th>
    <th align="left" valign="top" rowspan="1" colspan="1">SEARCH</th>
    <th align="left" valign="top" rowspan="1" colspan="1">ANRS TasP</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Cluster selection criteria </td>
    <td align="left" rowspan="1" colspan="1"> Located in one of three populated geographical regions of Botswana
     <break/> Geographically distinct communities, reachable by road
     <break/> Containing a government primary health care facility (clinic or hospital) which provides ART and PMTCT
     <break/> Community size 2500 to 15,000 (ideal 6000)
     <break/> Not site for other research activities that could impact the trial outcomes 
    </td>
    <td align="left" rowspan="1" colspan="1"> Located in the Hhohho region in Swaziland
     <break/> Catchment area of a government primary health care facility which provides HIV care
     <break/> Not a site for another research activity that could impact the trial outcomes 
    </td>
    <td align="left" rowspan="1" colspan="1"> Located in Western cape province of South Africa or Zambia
     <break/> Non‐adjacent communities
     <break/> Catchment area of a government primary health care facility which provides HIV and TB care
     <break/> Population ≥20,000
     <break/> High HIV prevalence
     <break/> Not site for other research activities that could impact the trial outcomes 
    </td>
    <td align="left" rowspan="1" colspan="1"> Located in Southwestern, Eastern Uganda or Western Kenya
     <break/> Non‐adjacent communities
     <break/> Served by a government primary health care facility which provides HIV care
     <break/> Accessibility to health centre via maintained transportation route
     <break/> Between 9000 and 11,0000 individuals, not in an urban setting i.e. ≤100,000
     <break/> Not site for other research activities that could impact the trial outcomes 
    </td>
    <td align="left" rowspan="1" colspan="1"> Located in the Hlabisa sub‐district in KwaZulu‐Natal province, South Africa
     <break/> Neighbouring communities with clear geographical boundaries and distinct social identities
     <break/> ≥15 km
     <sup>2</sup>
     <break/> Not site for other research activities that could impact the trial outcomes 
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Cluster matching and/or stratified randomization and/or restricted randomization criteria</td>
    <td align="left" rowspan="1" colspan="1"> Matching: geographical location, community size, population age structure, baseline access to health services including ART
     <break/> Randomized within matched pairs 
    </td>
    <td align="left" rowspan="1" colspan="1"> Matching: geographical location, clinic‐catchment size
     <break/> Stratified randomization 
    </td>
    <td align="left" rowspan="1" colspan="1"> Matching: geographical location, HIV prevalence
     <break/> Restricted randomization: Community size, ART uptake, HIV prevalence 
    </td>
    <td align="left" rowspan="1" colspan="1"> Matching: geographical location (Phase1 and 2), population density (Phase1), migration (Phase1), occupation (Phase1), number of trading centres (Phase1), Phase 1 intervention arm (Phase2), other drivers of HIV incidence (Phase2)
     <break/> Randomized within matched pairs 
    </td>
    <td align="left" rowspan="1" colspan="1"> No matching
     <break/> Stratified randomization: HIV prevalence 
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Number of clusters</td>
    <td align="left" rowspan="1" colspan="1">30</td>
    <td align="left" rowspan="1" colspan="1">14</td>
    <td align="left" rowspan="1" colspan="1"> 21
     <break/> (12 in Zambia
     <break/> and 9 in South Africa) 
    </td>
    <td align="left" rowspan="1" colspan="1"> 32
     <break/> (10 in Southwestern Uganda, 10 in Eastern Uganda and 12 in Kenya) 
    </td>
    <td align="left" rowspan="1" colspan="1">22</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Average cluster population size [range]
     <xref ref-type="fn" rid="jia225048-note-0009">a</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">5785 [2748 to 12,865]</td>
    <td align="left" rowspan="1" colspan="1">8553 [5326 to 14,868]</td>
    <td align="left" rowspan="1" colspan="1">44,000 [~16,000‐~100,000]</td>
    <td align="left" rowspan="1" colspan="1">10,450 [8401 – 12,990]</td>
    <td align="left" rowspan="1" colspan="1">1284 [324 to 2861] (for those aged ≥16 years old)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Intervention population size
     <xref ref-type="fn" rid="jia225048-note-0010">b</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">105,000 (age 16 to 64 years)</td>
    <td align="left" rowspan="1" colspan="1">4501</td>
    <td align="left" rowspan="1" colspan="1">~1000,000</td>
    <td align="left" rowspan="1" colspan="1">334,512</td>
    <td align="left" rowspan="1" colspan="1">28,260</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Intervention population eligibility criteria
     <xref ref-type="fn" rid="jia225048-note-0010">b</xref>
    </td>
    <td align="left" rowspan="1" colspan="1"> Gave verbal informed consent
     <break/> Is aged ≥16 years
     <break/> Is present at least three nights per month on average in the community over the prior 12 months
     <xref ref-type="fn" rid="jia225048-note-0009">a</xref>
     <break/> Is a Botswana citizen (or spouse of citizen)
     <xref ref-type="fn" rid="jia225048-note-0013">e</xref>
    </td>
    <td align="left" rowspan="1" colspan="1"> Gave verbal informed consent
     <break/> Is aged ≥18 years
     <break/> Is attending one of the study facilities
     <break/> Is not pregnant or breastfeeding at time of enrolment
     <break/> Is HIV‐positive and ART naïve 
    </td>
    <td align="left" rowspan="1" colspan="1"> Gave verbal informed consent
     <break/> Is aged ≥18 years (Year 1, first months of Year 2); all ages (1 October 2015 onwards) 
    </td>
    <td align="left" rowspan="1" colspan="1"> Gave verbal informed consent
     <break/> Is a member of a study household in the trial area 
    </td>
    <td align="left" rowspan="1" colspan="1"> Gave a written informed consent
     <break/> Is aged ≥16 years
     <break/> Is a member of a study household in the trial area 
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Research study population size
     <xref ref-type="fn" rid="jia225048-note-0011">c</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">22,000</td>
    <td align="left" rowspan="1" colspan="1">4501</td>
    <td align="left" rowspan="1" colspan="1">43,601</td>
    <td align="left" rowspan="1" colspan="1">146,906</td>
    <td align="left" rowspan="1" colspan="1">28,260</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Research study population eligibility criteria
     <xref ref-type="fn" rid="jia225048-note-0011">c</xref>
    </td>
    <td align="left" rowspan="1" colspan="1"> Gave written informed consent (or parental permission and child assent if &lt;18 years old)
     <break/> Is aged 16 to 64 years
     <break/> Is present at least three nights per month on average in the community over the prior 12 months
     <break/> Is a Botswana citizen (or spouse of citizen)
     <break/> Is present in one of the 20% randomly selected study households
     <break/> Is not currently incarcerated 
    </td>
    <td align="left" rowspan="1" colspan="1"> Gave written informed consent
     <break/> Is a participant to the intervention population 
    </td>
    <td align="left" rowspan="1" colspan="1"> Gave written informed consent
     <break/> Is a member of the trial population
     <break/> Is aged ≥18 and ≤44 years
     <break/> Is present in one of the 2500 study households randomly selected in each cluster; and intending to remain so for the next 3 years
     <break/> Is not currently enrolled in another ART or PreP study
     <break/> Has not been or is not currently enrolled in an HIV vaccine study 
    </td>
    <td align="left" rowspan="1" colspan="1"> Gave verbal informed consent
     <break/> Is a member of the intervention population
     <break/> Is aged ≥15 years at baseline
     <break/> Is present in a study community for ≥6 months of the year prior the study start 
    </td>
    <td align="left" rowspan="1" colspan="1">Is a member of the intervention population</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Evaluation population size
     <xref ref-type="fn" rid="jia225048-note-0012">d</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">9000</td>
    <td align="left" rowspan="1" colspan="1">4501</td>
    <td align="left" rowspan="1" colspan="1">~33,000</td>
    <td align="left" rowspan="1" colspan="1">118,038</td>
    <td align="left" rowspan="1" colspan="1">17,659</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Evaluation population eligibility criteria
     <xref ref-type="fn" rid="jia225048-note-0012">d</xref>
    </td>
    <td align="left" rowspan="1" colspan="1"> Is a member of the research study population
     <break/> Is HIV‐negative at baseline 
    </td>
    <td align="left" rowspan="1" colspan="1">Is a member of the research study population</td>
    <td align="left" rowspan="1" colspan="1"> Is a member of the research study population
     <break/> Is HIV‐negative 
    </td>
    <td align="left" rowspan="1" colspan="1"> Is a member of the research study population
     <break/> Is HIV‐negative at baseline 
    </td>
    <td align="left" rowspan="1" colspan="1"> Is a participant to the research study population
     <break/> Is HIV‐negative at baseline 
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="jia225048-note-0008">
   <p>PMTCT, prevention of mother‐to‐child transmission; ART, antiretroviral therapy; PrEP, pre‐exposure prophylaxis.</p>
  </fn>
  <fn id="jia225048-note-0009">
   <label>a</label>
   <p>Cluster population: Total population of a trial cluster (estimated with baseline data).</p>
  </fn>
  <fn id="jia225048-note-0010">
   <label>b</label>
   <p>Intervention Population: Population that is eligible for trial interventions, which for purposes of this definition are testing services in the ANRS TasP, BCPP, PopART and SEARCH trials, or HIV treatment services in the 
    <italic>Max</italic>ART trial (estimated with baseline trial data).
   </p>
  </fn>
  <fn id="jia225048-note-0011">
   <label>c</label>
   <p>Research study population: Population in which the primary outcome and main secondary outcomes (among adults) are being measured (estimated with baseline data).</p>
  </fn>
  <fn id="jia225048-note-0012">
   <label>d</label>
   <p>Evaluation population: Population in which the trial impact is being evaluated i.e. in which the primary outcome is being measured (estimated with baseline data).</p>
  </fn>
  <fn id="jia225048-note-0013">
   <label>e</label>
   <p>In the BCPP trial, being a Botswana citizen (or spouse of a Botswana citizen) and being present at least three nights per month on average in the community over the prior 12 months are eligibility criteria to access early ART but not to access HIV testing and counselling).</p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
